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A Swedish patient of Indian origin traveled to New Delhi, India, and acquired a urinary tract infection
caused by a carbapenem-resistant Klebsiella pneumoniae strain that typed to the sequence type 14 complex. The
isolate, Klebsiella pneumoniae 05-506, was shown to possess a metallo--lactamase (MBL) but was negative for
previously known MBL genes. Gene libraries and amplification of class 1 integrons revealed three resistance-
conferring regions; the first contained blaCMY-4 flanked by ISEcP1 and blc. The second region of 4.8 kb
contained a complex class 1 integron with the gene cassettes arr-2, a new erythromycin esterase gene; ereC;
aadA1; and cmlA7. An intact ISCR1 element was shown to be downstream from the qac/sul genes. The third
region consisted of a new MBL gene, designated blaNDM-1, flanked on one side by K. pneumoniae DNA and a
truncated IS26 element on its other side. The last two regions lie adjacent to one another, and all three regions
are found on a 180-kb region that is easily transferable to recipient strains and that confers resistance to all
antibiotics except fluoroquinolones and colistin. NDM-1 shares very little identity with other MBLs, with the
most similar MBLs being VIM-1/VIM-2, with which it has only 32.4% identity. As well as possessing unique
residues near the active site, NDM-1 also has an additional insert between positions 162 and 166 not present
in other MBLs. NDM-1 has a molecular mass of 28 kDa, is monomeric, and can hydrolyze all -lactams except
aztreonam. Compared to VIM-2, NDM-1 displays tighter binding to most cephalosporins, in particular,
cefuroxime, cefotaxime, and cephalothin (cefalotin), and also to the penicillins. NDM-1 does not bind to the
carbapenems as tightly as IMP-1 or VIM-2 and turns over the carbapenems at a rate similar to that of VIM-2.
In addition to K. pneumoniae 05-506, blaNDM-1 was found on a 140-kb plasmid in an Escherichia coli strain
isolated from the patient’s feces, inferring the possibility of in vivo conjugation. The broad resistance carried
on these plasmids is a further worrying development for India, which already has high levels of antibiotic
resistance.
The growing increase in the rates of antibiotic resistance is a
major cause for concern in both nonfermenting bacilli and
isolates of the Enterobacteriaceae family. -Lactams have been
the mainstay of treatment for serious infections, and the most
active of these are the carbapenems, which are advocated for
use for the treatment of infections caused by extended-spec-
trum -lactamase (ESBL)-producing Enterobacteriaceae, par-
ticularly Escherichia coli and Klebsiella pneumonia (21). How-
ever, carbapenemases are increasingly being reported; and the
most prevalent of these would appear to be KPC, which has
recently been characterized in the United States, Israel, Tur-
key, China, India, the United Kingdom, and Nordic countries
(20, 24, 26). KPC has invariably been found in K. pneumoniae,
although recent reports indicate that it can cross species
boundaries (2). OXA-48 is a class D carbapenemase that is
mainly found in K. pneumoniae and that is now reported from
Turkey, China, India, and the United Kingdom (3, 5, 9). The
mobile class B enzymes or metallo--lactamases (MBLs) have
been mainly found in Pseudomonas aeruginosa, but they are
increasingly being found in Enterobacteriaceae, particularly iso-
lates from Greece and Turkey (39). Those mainly found in K.
pneumoniae are the VIM-1/VIM-4 cluster (6).
The majority of resistance genes in Enterobacteriaceae are
carried on class 1 integrons, and this is also true for the car-
bapenemases, such as VIM-1/VIM-4 (24, 40). In such cases,
the genes are mobilized and evinced as gene cassettes and can
theoretically move as separate entities independent of the in-
tegrase gene. Indeed, the majority of the mobile MBL genes
are found as gene cassettes. These include blaIMP, blaVIM,
blaGIM, blaSIM, and blaKMH (41). The exception to these are
genes encoding AIM-1 and SPM-1, which are adjacent to and
thought to be mobilized by ISCR elements via a transposition
event called rolling circle recombination (36).
Herein, we report on the genetic and biochemical charac-
terization of a new subgroup of MBL, designated NDM-1,
originating from New Delhi, India. We also report on its novel
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genetic context and describe a new erythromycin resistance
gene, designated ereC.
MATERIALS AND METHODS
Bacterial strains and susceptibility testing. The identification of K. pneu-
moniae 05-506 was performed with automated systems (the Phoenix and BD
systems). Etest strips (AB bioMerieux, Solna, Sweden) were used to determine
susceptibility, and the susceptibility results were interpreted according to the
CLSI guidelines. E. coli J53 and E. coli TOPO (Strategene, Amsterdam, The
Netherlands) were used in the conjugation and cloning experiments, respectively.
Phenotypic and molecular detection of MBL. Hodge and imipenem-EDTA
double-disc synergy tests as well as Etest were used to screen for MBL produc-
tion. In addition, the carbapenemase activities of cell sonicates from overnight
broth cultures (Mueller-Hinton broth; BD) were determined by spectrophoto-
metric assays. These were undertaken by using 150 M imipenem as the sub-
strate and 299 nm for the measurement of hydrolysis. The assays were performed
with or without EDTA (25 mM) to examine the inhibition of carbapenemase
activity. The strains were screened for the presence of known mobile MBL genes
(blaVIM, blaIMP, blaSPM-1, blaGIM-1, blaSIM-1, blaAIM-1) by PCR with the primers
reported previously (22). The strains were also screened for the presence of other
-lactamase genes (blaCTX, blaCMY, etc.) as well as class 1, 2, and 3 integron
structures (24). Strains known to harbor MBL genes were used as positive
controls for the PCR analysis.
Conjugation. E. coli J53 was used as the recipient in the conjugation studies,
and mating was carried out on blood agar medium without selection (25). After
18 h, the mixed cultures were taken from the plates, suspended in saline, and
plated onto MacConkey medium containing sodium azide (100 g/ml) and
ceftazidime (8 g/ml). Confirmation that conjugation had taken place in E. coli
J53 was carried out by indole testing and testing for the presence of the MBL
gene by PCR analysis.
DNA cloning. Cloning experiments were performed by using the cloning vector
pK18, as described previously (35). Restriction endonucleases BamHI, EcoRI,
and HindIII (Invitrogen, Carlsbad, CA) were used to cut both plasmid and K.
pneumoniae 05-506 chromosomal DNA. Transformation was carried out by using
electroporation and E. coli TOP10 cells (Invitrogen Ltd, Paisley, United King-
dom). Transformants were selected on LB agar plates containing 5-bromo-4-
chloro-3-indolyl--D-galactopyranoside (30 g/ml), ceftazidime (6 g/ml), and
kanamycin (25 g/ml). Recombinant plasmids were recovered with a QIAprep
spin miniprep kit (Qiagen, West Sussex, United Kingdom). Restriction endonu-
clease analysis of the plasmid was carried out with a variety of restriction en-
zymes to determine the size of the ligated nucleotide segment.
The PCR-amplified open reading frame of NDM-1 was digested with the
appropriate enzymes and was subsequently ligated into the pVFT3S (six-His—trx
fusion vector) bacterial expression vector. The construct was transformed into E.
coli BL21 groEL/groES (pGro7/BL21; Takara Bio Inc., Japan).
DNA sequencing and computer analysis. Both strands of the clones from the
libraries that were produced were sequenced by using M13 forward and M13
reverse primers. The cloned insets containing blaNDM-1, the complex class 1
integron, and blaCMY-4 were fully sequenced. The nucleotide sequences, deduced
amino acid sequences, and phylogenetic relationships were analyzed by using the
Lasergene software package (DNAStar, Madison, WI). The sequences obtained
were compared to the sequences available on the Internet (http://www.ebi.ac.uk
/fasta33/).
Pulsed-field gel electrophoresis (PFGE) and genomic DNA digestion with
endonucleases. Genomic DNA was prepared in agarose blocks and digested with
the restriction enzymes XbaI and SpeI (Roche Diagnostics, Mannheim, Ger-
many), I-CeuI (New England Biolabs, Beverly, MA), and S1 nuclease (Invitro-
gen, Abingdon, United Kingdom). The DNA fragments were separated by use of
a CHEF-DR III apparatus (Bio-Rad, Hercules, CA) for 20 h at 6 V/cm and 14°C
with initial and final pulse times of 0.5 and 30 s, respectively.
Southern blot analysis. Southern blotting was performed on agarose gels by
in-gel hybridization with the blaNDM-1 probe labeled with 32P (Strategene) and by
a recently described random primer method (22).
MLST. Multilocus sequence typing (MLST) of K. pneumoniae was performed
as described by Diancourt et al. (7). Experimentally determined DNA sequences
were uploaded into the MLST database (http://www.pasteur.fr/recherche
/genopole/PF8/mlst/Kpneumoniae.html), and allelic numbers as well as sequence
types (STs) were obtained.
ß-Lactamase purification. Cell lysates were centrifuged at 12,000 rpm for 30
min at 4°C. The supernatant was obtained and loaded onto Ni-nitrilotriacetic
acid agarose. The NDM-1 protein was eluted by the use of elution buffer with 300
mM imidazole. The protein was separated from the His-trx tag by tobacco etch
virus protease and was finally purified by gel filtration on a GS320 column.
Kinetic measurements. Purified ß-lactamase was used to determine the kinetic
parameters kcat and Km. Reactions were performed at 30°C in 1 ml of assay buffer
(10 mM HEPES, pH 7.5). The assays were performed in a UV-1601PC spectro-
photometer (Shimadzu Corp., Tokyo, Japan) by observing the changes in ab-
sorption resulting from the opening of the ß-lactam ring at the specific wave-
lengths for each of the each antimicrobial agents evaluated, as described
previously (18).
Nucleotide sequence accession number. The nucleotide sequence data re-
ported in the present study have been assigned EMBL/GenBank nucleotide
accession number FN396876.
RESULTS
Clinical details for K. pneumoniae 05-506. A 59-year-old
male patient who was originally from India but who had lived
in Sweden for many years and who often returned to India had
type 2 diabetes mellitus and had had multiple strokes. In
November 2007, he traveled to India and on 5 December was
hospitalized in Ludhiana, Punjab, with a large gluteal abscess.
In December 2007, he was admitted to a hospital in New Dehli,
where he was again operated on and where he developed a
decubital ulcer. On 8 January 2008 he was referred to O¨rebro,
Sweden. During his stay in New Dehli he received amoxicillin
(amoxicilline)-clavulanic acid, metronidazole, amikacin, and
gatifloxacin (all of them parenterally).
Clinical isolate K. pneumoniae 05-506 was derived from a
urinary culture on 9 January 2008. He had no clear symptoms
of urinary tract infection at that time. The amount of bacteria
found in a culture of his urine was only 1,000 CFU/ml. Both
ESBL-positive Escherichia coli and a carbapenem-susceptible
Acinetobacter sp. were isolated from his deep wounds. An
ESBL-positive E. coli strain was also found in a culture of fluid
resulting from external otitis.
On 6 March 2008, the patient was discharged to a nursing
home. On 1 April a new urine sample for culture was taken,
and an ESBL-producing K. pneumoniae isolate was found. The
original carbapenem-resistant K. pneumoniae isolate has never
been found in any other cultures of samples from the patient.
As K. pneumoniae 05-506 was carbapenem resistant and posi-
tive by the MBL Etest (AB bioMerieux), it was investigated
further. Moreover, fecal samples were collected from the pa-
tient during his stay at the nursing home to identify the source
of 05-506; however, while 05-506 could not be recovered, an
MBL-positive E. coli isolate was recovered and was designated
E. coli NF-NDM-1.
Typing and phenotypic characterization of K. pneumoniae
05-560, E. coli NF-NDM-1, and transformants. ST14 is a sin-
gle-locus variant of ST15, which has been encountered with
KPC- and CTX-M-producing K. pneumoniae strains (19, 30).
We have also found ST14 among U.S. KPC producers (19).
The susceptibility patterns of K. pneumoniae 05-560, E. coli
NF-NDM-1, E. coli TOP10, E. coli TOP10(pNDM-1), E. coli
J53, and E. coli J53(pNDM-1) are listed in Table 1. K. pneu-
moniae 05-560 was resistant to all -lactams and was sensitive
only to colistin (Table 1). The susceptibility profile of E. coli
NF-NDM-1 largely reflects that of 05-560, apart from suscep-
tibility to aztreonam, cefepime, and ciprofloxacin, to which the
level of resistance of 05-560 was not quite as high. When the
cloned MBL gene and its adjacent DNA were expressed in an
E. coli background, the strain was highly resistant to all ceph-
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alosporins, apart from cefepime (MIC, 8 g/ml), and was sen-
sitive to aztreonam. However, the aztreonam MICs differed
significantly for TOP10 blaNDM-1 (MIC, 0.25 g/ml) and J53
blaNDM-1 (MIC, 24 g/ml), even though the aztreonam MICs
for TOP10 and J53 were very similar. Interestingly, the MICs
of imipenem and meropenem were relatively high for both E.
coli TOP10 and J53 compared with those for strains with the
other cloned MBL genes (31, 41).
Phenotypic and molecular screening for MBLs. The results
of the MBL screening tests were positive by the imipenem-
EDTA double-disc synergy test, the MBL Etest (256 g/ml
with imipenem and 3 g/ml with imipenem plus inhibitor), and
the determination of carbapenemase activities by spectropho-
tometry (data not shown). However, PCR analysis failed to
detect previously known MBL genes when the control genes
blaVIM, blaIMP, blaSPM-1, blaGIM-1, blaSIM-1, blaAIM-1 were
used. PCR did detect a class 1 integron (intI and qacE1/sul)
of 4.8 kb.
Nucleotide and deduced amino acid sequences of three re-
sistance-conferring regions. Total DNA from K. pneumoniae
05-560 was used to construct a genomic library to isolate all
genes conferring -lactam resistance. After the plasmids of
resistant colonies were analyzed by restriction profiling, it was
evident that there were two different types of -lactam resis-
tance. One group carried a putative AmpC enzyme, on the
basis of the fact that it was resistant to the effects of EDTA but
sensitive to inhibition with cloxacillin. The other group pos-
sessed a putative MBL on the basis of the fact that it was
resistant to the effects of cloxacillin and clavulanic acid but
sensitive to EDTA. Restriction of the recombinant plasmids
showed that the AmpC-type genes are carried on a 2.1-kb
fragment and that the MBL gene is carried on a 4.3-kb frag-
ment. Additionally, the 4.8-kb fragment containing the class 1
integron was also sequenced.
The class 1 integron contains a unique set of genes, some of
which have been previously reported from Asia. Immediately
next to the intI gene is an arr-2 cassette that mediates resis-
tance to rifampin (rifampicin) and that has been found in
isolates of Pseudomonas aeruginosa and Acinetobacter bauman-
nii from China and Hong Kong, respectively (GenBank acces-
sion numbers EU886979 and AY038837, respectively) (1, 14,
27, 38). It has also been identified on the chromosome of Strep-
tomyces coelicolor (GenBank accession number NC003888).
Next to aar-2 is a novel erythromycin esterase gene (ereC)
which has 92% nucleotide sequence identity with ereA from
E. coli (GenBank accession number AY183453) (Fig. 1). The
predicted protein sequence differs from the EreA sequence at
an additional 10 amino acids at the N terminus and also has 31
amino acid substitutions throughout the sequence. At present,
only two erythromycin esterases, ereA and ereB, have been
found (GenBank accession numbers DQ157752 and X03988,
respectively), and these share only 25% identity in their amino
acid sequences (Fig. 1). Adjacent to the esterase gene is aadA1,
which mediates resistance to gentamicin, and the cmlA7 gene
cassette, which mediates resistance to chloramphenicol, is
present between aadA1 and qac/sul (Fig. 2).
The AmpC fragment is shown in Fig. 2 and carries blaCMY-4,
which is responsible for the AmpC phenotype. Upstream of
blaCMY-4 is an intact copy of ISEcP1, which is probably respon-
sible for the transposition and mobility of blaCMY-4. Down-
stream is blc, which is a common feature in many blaCMY
regions and which has been reported by Kang et al. (16).
The 4.3-kb fragment contained a novel MBL gene, desig-
nated blaNDM-1 (Fig. 2). This section of DNA was a chimera of
truncated and intact genes. The blaNDM-1 gene was found
between a section of K. pneumoniae chromosomal DNA and
truncated sections of the IS26 and Tn3 transposase genes. The
Klebsiella DNA consisted of a putative efflux protein gene
adjacent to another gene encoding L-lactate hydrogenase, and
both were 99.5% identical to a section of chromosomal DNA
from K. pneumoniae MGH78578 (GenBank accession number
CP000647) and found in the same orientation in which they are
present on the Klebsiella chromosome. The lactate dehydroge-
nase gene was truncated and missing approximately 750 bp of
the 5 end of the gene. Immediately upstream of the lactate
dehydrogenase gene was a short internal part of the ampC
gene, blaDHA-1 (base pair coordinates 1268 to 1478), consisting
of the DNA encoding amino acids 196 to 265. This gene was
truncated at both ends both by the lactate dehydrogenase gene
and by a section of DNA encoding the 5 end of a phosphori-
bosyl anthalinate isomerase gene. This section of DNA (coor-
dinates 1478 to 2100) has identities ranging from 55% to 68%
TABLE 1. Antimicrobial susceptibility patterns of K. pneumoniae 05-560, E. coli NF-NDM-1, transformants, and conjugants
Antibiotic
MIC (g/ml)
K. pneumoniae
05-560 E. coli TOP10
E. coli
TOP10(NDM-1) E. coli J53
E. coli
J53(pNDM-1)
E. coli
NF-NDM-1
Ampicillin 256 12 256 4 256 256
Piperacillin 256 0.5 NT 1 256 256
Cephalothin 256 8 256 4 256 256
Cefoxitin 256 4 256 2 256 256
Cefotaxime 256 0.125 256 0.064 256 256
Cefuroxime 256 8 256 8 256 256
Ceftazidime 256 1 256 0.125 256 256
Aztreonam 256 0.094 0.25 0.064 24 24
Cefepime 256 0.032 8 0.064 24 24
Ertapenem 32 0.125 24 0.5 32 32
Imipenem 32 0.094 12 0.25 16 32
Meropenem 32 0.064 12 0.064 32 32
Ciprofloxacin 32 0.004 0.006 0.032 0.047 4
Colistin 0.75 0.38 0.38 0.25 0.25 0.25
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to the same gene from various members of the alphapro-
teobacteria, including Rhodobacter spp., Rhodopseudomonas
spp., Caulobacter spp., and Novosphingobium spp. The highest
degree of identity was found with Novosphingobium aromati-
civor, with 68% nucleotide sequence identity over 575 nucleo-
tides. Again, this gene was truncated and missing the DNA
encoding the last 19 amino acids of the C terminus of the
protein. The blaNDM-1 gene is encoded within a 1,350-bp sec-
tion of DNA with a lower GC content (57%) than that of the
surrounding DNA, which has a GC content of 62 to 65% and
which consists of a gene of 807 nucleotides and flanking DNA
on either side. Upstream of the blaNDM-1 gene is 250 nucleo-
tides of DNA that contains several sequences that show simi-
larity to conventional promoter sequences, and it is likely that
the promoter driving the expression of blaNDM-1 has been
acquired along with the gene (Fig. 2). Farther upstream is a
truncated left-hand end of an IS26 insertion sequence, includ-
ing 270 bp of the left-hand end of the element with the left-
hand inverted repeat and DNA encoding the first 74 amino
acids of the transposase. This element lies adjacent to a tnpA
gene of a Tn3-like transposon (coordinates 3748 to 4318),
which is itself truncated and missing the 5 end of the gene
encoding the first 128 amino acids of the transposase (Fig. 2).
Structural properties of NDM-1. The blaNDM-1 open read-
ing frame encodes a putative protein of 269 amino acids with
a molecular mass of approximately 27.5 kDa (Fig. 3). The
NDM-1 sequence and the behavior of NDM-1 during gel fil-
tration and mass spectrometry (data not shown) indicate that it
FIG. 1. Alignment of novel erythromycin esterase EreC (this study) with EreA and EreA2. Amino acid changes between EreC and EreA are
indicated with asterisks. The single amino acid difference between EreA and EreA2 is highlighted in gray.
FIG. 2. Three characterized antibiotic resistance-conferring regions from K. pneumoniae 05-506. (A) The 4.3-kb region is linked to the 4.8-kb
complex class 1 integron region. The genes encoding the efflux pump and lactate dehydrogenase (gray diagonal lines) are of Klebsiella origin.
blaNDM-1 (dark gray) is flanked between the pathogenicity island (vertical black lines) and IS26/Tn3 (black small squares). This region lies
downstream of the 4.8-kb complex class 1 integron containing Int (checkered area), arr-2, ere2A, aadA1, and cmlA7 as gene cassettes and qac1
(white boxes). Downstream is an intact copy of ISCR1 (black and white diagonal lines). Arrows, direction of transcription; black ellipses, 59-base
elements; , genes that are truncated. (B) blaCMY-4 (gray) is located between ISEcP1 (black) and blc (white), as reported previously (16).
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is actively present as a monomer. Sodium dodecyl sulfate-
polyacrylamide gel electrophoresis analysis showed an approx-
imate molecular mass of 28 kDa (data not shown). NDM-1
possesses a leader peptide, with the probable cleavage site
occurring at position 19 between two alanines which are in a
very similar position to the cleavage site for the VIM MBLs
(Fig. 3). NDM-1 also shares the additional loop of the VIM
enzymes at positions 34 and 47 but also possesses a unique
additional sequence at positions 162 to 166 (blaNDM-1 and not
BBL numbering) (Fig. 3) (4). NDM-1 shares very little identity
with other MBLs and is the most closely related to VIM-1/
VIM-2, with which it has only 32.4% identity (Fig. 4). Curi-
ously, NDM-1 also has a unique HXHXD motif among the
mobile MBLs, as it contains an alanine between the two his-
tidines. NDM-1 also possesses a tyrosine at position 222 in-
stead of the universally conserved tryptophan (Fig. 3). The
mature peptide has a theoretical pI of 6.9.
Functional properties of NDM-1. Analysis of the purified
NDM-1 enzyme by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis analysis showed a single band corresponding to
a size of 28 kDa (data not shown). Table 2 lists the kcat and Km
values and compares them with the kinetic values of IMP-1 and
VIM-2. NDM-1 shows tight binding (low Km values) to most
cephalosporins and, in particular, to cefuroxime, cefotaxime,
and cephalothin (cefalotin). It also shows relatively tight bind-
ing to the penicillins, which is unusual for an MBL, as both
IMP-1 and VIM-2 possess higher Km values (Table 2). Inter-
estingly, NDM-1 does not bind to the carbapenems as tightly as
IMP-1 or VIM-2. The rate of turnover (kcat) of penicillins by
NDM-1 is lower than that by IMP-1 and VIM-2 and is gener-
FIG. 3. Alignment of the amino acid sequences of NDM-1 with the amino acid sequences of IMP-1, IMP-2, IMP-8, VIM-1, VIM-2, GIM-1,
SPM-1, SIM-1, and KHM-1. Conserved residues coordinating zinc ions are denoted with asterisks. Key amino acids are also numbered according
to the BBL scheme (12). Additional amino acids unique to NDM-1 are enclosed in a light gray box. Amino acid substitutions near the active site
are highlighted in plain boxes (13).
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ally unusual for MBLs. The kcat values for the cephalosporins
are more similar to those of IMP-1 than to those of VIM-2, yet
the kcat values for the carbapenems (20 and 12 s
1 for imi-
penem and meropenem, respectively) are more similar to
those for VIM-2 (10 and 1 s1, respectively) than IMP-1 (46
and 50 s1, respectively) (Table 2). Due to the fact that most
of the Km values are low, the kcat/Km ratios are reasonably high
and comparable to those of VIM-2. The exception is that of
ceftazidime, which has a Km of 181 M and a kcat of 5 s
1 and
which thus presents with a kcat/Km of 0.03.
Plasmid analysis and back probing with blaNDM-1. The plas-
mids carrying blaNDM-1 from both K. pneumoniae 05-506 and
E. coli NF-NDM-1 were successfully transferred to E. coli J53
at a frequency of approximately 104 to 105. PCR was un-
dertaken with primers directed to ISCR1 and blaNDM-1, and
both were shown to be carried by pNDM-1. To examine the
sizes of the plasmids from 05-506, E. coli J53(pNDM-1), and E.
coli NF-NDM-1, genomic DNA was isolated from each of the
strains, restricted with S1 nuclease, and examined by PFGE.
The corresponding gel was blotted with blaNDM-1, and the data
clearly show that blaNDM-1 is on a 180-kb plasmid in 05-506 and
E. coli J53(pNDM-1), but in E. coli NF-NDM-1 it is on a
smaller plasmid of 140 kb (Fig. 5). Inc typing was unsuccessful,
and plasmid pNDM-1 is currently being sequenced to identify
the origin of replication and other functions carried by
pNDM-1.
As the broader genetic context was not known and ISCR1
had been found in a large antibiotic resistance-conferring re-
gion, K. pneumoniae 05-506 was also digested with XbaI, SpeI,
I-CeuI, and S1 nuclease and was then probed with radiolabeled
blaNDM-1. The probing results were compared to those of prob-
ing of ISCR1 to ascertain whether blaNDM-1 and ISCR1 are on
the same genetic structure (Fig. 6). The probing data for
ISCR1 and blaNDM-1 are identical and clearly indicated prob-
ing to the same 25-kb region, suggesting that the regions are
adjacent to one another.
DISCUSSION
K. pneumoniae 05-506 types as ST14, a single-locus variant of
type ST15. Recently, K. pneumoniae ST15 has been branded as
a new methicillin-resistant S. aureus type of pathogen due to its
wide distribution and its carriage of blaCTX-M15 and other
resistance markers (19, 30). Strain 05-506 clearly arose in In-
dia, but there are few data arising from India to suggest how
widespread it is. We are currently undertaking studies in sev-
eral Indian cities to examine these points. Interestingly, there
appears to be the possible transfer of blaNDM-1 in vivo either
FIG. 4. Phylogenetic tree obtained for MBL subgroup B1. The numbers for the substitutions should be multiplied by 100. The alignment used
was prepared with the CLUSTALW program. The GenBank accession numbers for the sequences are as follows: IMP-1, S71932; IMP-2,
AJ243491; IMP-8, AF322577; VIM-1, Y18050; VIM-2, AF191564; GIM-1, AJ620678; SPM-1, AJ492820; SIM-1, AY887066; KHM-1, AB364006.
TABLE 2. Steady-state kinetic constants of NDM-1, IMP-1, and VIM-2
Compound
NDM-1 IMP-1a VIM-2b
Km (M) kcat (s1)
kcat/Km
(s1/M) Km (M) kcat (s
1) kcat/Km(s1/M) Km (M) kcat (s
1) kcat/Km(s1/M)
Penicillin G 16 11 0.68 520 320 0.62 49 56 1.14
Ampicillin 22 15 0.66 200 950 4.8 DNA
Piperacillin 12 14 1.17 NDc ND ND 72 33 0.45
Cephalothin 10 4 0.40 21 48 2.4 44 57 1.28
Cefoxitin 49 1 0.02 8 16 2 24 3 0.12
Cefotaxime 10 6 0.58 4 1.3 0.35 32 28 0.86
Cefuroxime 8 5 0.61 37 8 0.22 22 12 0.55
Ceftazidime 181 5 0.03 44 8 0.18 98 89 0.90
Aztreonam ND 1,000 0.01 0.0001 ND 0.5 ND
Cefepime 77 13 0.17 11 7 0.66 184 5 0.03
Imipenem 94 20 0.21 39 46 1.2 10 10 0.99
Meropenem 49 12 0.25 10 50 0.12 5 1 0.28
Clavulanic acid ND NRd NR
a From Spencer et al. (32).
b From Poirel et al. (23).
c ND, not detected.
d NR, not reported.
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from K. pneumoniae to E. coli or vice versa, but more inter-
estingly, the plasmids carrying blaNDM-1 in the two species are
of different sizes. This evidence would suggest that there is
rearrangement in vivo which could result from either duplica-
tion and insertion, e.g., transposition or rolling circle replica-
tion from the smaller plasmid, or deletion from the larger
plasmid (33, 34). The plasmid carrying blaNDM-1 also carries
blaCMY-4 and the complex class 1 integron carrying several
antibiotic resistance-conferring genes (33), and it has also
shown itself to naturally have a broad host range. When the
plasmid was transferred to E. coli J53, the E. coli strain con-
taining pNDM-1 was resistant to all antibiotics except colistin
and ciprofloxacin and was shown by blotting and PCR to carry
blaCMY-4, the ISCR region, and blaNDM-1. Therefore, the rapid
dissemination of this plasmid among clinical bacteria would be
a nightmare scenario.
This is the first report of an MBL gene not carried in a class
1 integron or adjacent to ISCR1 elements. It appears to have
an intact promoter sequence that is not dependent on the IS26
element inserted upstream, even though IS26 is found adjacent
to other resistance genes and pathogenicity islands (8, 10, 11,
15). The plasmid clearly contains Klebsiella housekeeping
genes (Fig. 2) as part of this capturing DNA machinery, and
therefore, these have probably been purloined from the Kleb-
siella chromosome. Furthermore, restriction digests and prob-
ing experiments indicate that blaNDM-1 and ISCR1 are on a
DNA fragment of less than 25 kb (Fig. 6). While Tn3 and IS26
are capable of movement, the amelioration of such a large
region spanning from blaNDM-1 to ISCR1 could have occurred
only through a series of duplications and homologous recom-
bination (34). The known location of ISCR1 in all sequences
analyzed so far is at the end of a complex class 1 integron that
is more often than not contained within a Tn3-like transposon,
and therefore, it is possible that the ISCR1 element is upstream
of the blaNDM-1 gene and farther downstream of the Tn3 trans-
posase. Additionally, the chimeric structure of the 4.3-kb insert
with its composition of fused truncated and nontruncated
genes is a classic signature of ISCR1 transposition activity (22,
34, 37).
NDM-1 not only is a new subclass of the B1 group of MBLs
but also possesses novel amino acids near the active site, sug-
gesting that it has a novel structure. NDM-1 possesses only
32.4% identity with VIM-2, and therefore, molecular replace-
ment or threading cannot be undertaken to reasonably ascer-
tain its structure. However, NDM-1 does show some similari-
ties to the VIM group of MBLs; namely, it possesses the
additional sequences at positions 226 to 228 (BBL numbering)
not present in other MBLs (12). These residues contain R228
in VIM-2, which is thought to stabilize C221 and possibly
H263, yet in NDM-1 the substitute R228A is unlikely to play
such a role. VIM-2 also possesses Y224, which is in close
proximity to C221, whereas NDM-1 has a lysine, which is likely
to serve a similar role. Crystallographic insights into the mech-
anism of action of VIM-2 by Garcia-Saez et al. suggest that
Y67 pivots in toward the enzyme away from bulk solvent and
in so doing stabilizes H263; but NDM-1, like other non-VIM
MBLs, possesses the substitution Y67V, which is unlikely to
function in the same manner (13). However, NDM-1 does
possess S69, which is in close proximity to Y67 and less so to
R121 and H263 (13). The role of these substitutions is not
apparent, as NDM-1 possesses kinetics similar to those of
VIM-2 (23, 29). In general, NDM-1 binds more tightly (it has
a lower Km) to most -lactam substrates and hydrolyzes them
less well (it has a lower kcat), with the exception being the less
bulky carbapenems, for which NDM-1 possesses relatively
high Km and kcat values for both imipenem and meropenem
(23, 29).
In addition to blaNDM-1, this study also characterized a new
erythromycin esterase gene, designated ereC (28). The esterase
gene is part of the complex class 1 integron containing the
Asian rifampin resistance gene, arr-2, which is also contained
as a gene cassette (17). If this structure is stable, together with
blaNDM-1, it will act as a unique genetic marker for the prev-
alence and stability of plasmid pNDM-1 throughout Indian
FIG. 5. PFGE of plasmids from K. pneumoniae 05-506, conju-
gant E. coli J53(pNDM-1), and E. coli NF-NDM-1 (from the pa-
tient’s normal flora). The bands with white arrows showed positive
signals by Southern blot hybridization with the NDM-1 probe (data
nor shown). K. pneumoniae 05-506 carries blaNDM-1 on a 180-kb
plasmid, whereas E. coli NF-NDM-1 carries blaNDM-1 on a plasmid
of approximately 140 kb.
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Enterobacteriaceae strains. We are currently doing molecular
epidemiological studies of Indian Enterobacteriaceae carbap-
enem-resistant strains to examine the prevalence and range of
pNDM-1 among clinical and nonclinical isolates. In a country
where there is little control on antibiotic prescriptions, the
rapid dissemination of such a plasmid is alarming.
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